✦ LIBER ✦

246 A comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus (HBV) infection

✍ Scribed by Florian van Bömmel; Thomas Wünsche; Dirk Schürmann; Alexandra Bergk; Bertram Wiedenmann; Uwe Hopf; Thomas Berg

Book ID: 119530155
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 118 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80289-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adefovir and tenofovir in

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

✍ Florian van Bömmel; Thomas Wünsche; Stefan Mauss; Petra Reinke; Alexandra Bergk; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudineresistant hepatitis B virus (HBV) infection. Tenofovir disoproxil fumarate, a congender of adefovir that is used in the treatment of HIV infected patients, has recently been shown to also be effective in patients w

Tenofovir for patients with lamivudine-r

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy

✍ Florian van Bömmel; Bernhard Zöllner; Christoph Sarrazin; Ulrich Spengler; Dietr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

1164 susceptibility of wild-type and lam

1164 susceptibility of wild-type and lamivudine-resistant hepatitis B virus to tenofovir and adefovir

✍ LADA, O; BENHAMOU, Y; VALANTIN, M; KATLAMA, C; POYNARD, T; CAHOUR, A; THIBAULT, 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Efficacy of adefovir dipivoxil in the tr

Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection

✍ Do Young Kim; Hong Jeoung Kim; Chun Kyon Lee; Jeong Hun Suh; Dong Hwan Kim; Yong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Switching patients with lamivudine resis

Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression

✍ W. F. Leemans; H. L. A. Janssen; H. G. M. Niesters; R. A. De Man 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Use of adefovir in the treatment of the

Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine

✍ R Barcena Marugan; L Cid Gomez; P Lopez Serrano 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 53 KB